Cargando…
Is D2 Lymphadenectomy Alone Suitable for Gastric Cancer With Bulky N2 and/or Para-Aortic Lymph Node Metastases After Preoperative Chemotherapy?
BACKGROUND: For gastric cancer (GC) with extensive lymph node metastasis (bulky N2 and/or para-aortic lymph node metastases), there is no standard therapy worldwide. In Japan, preoperative chemotherapy (PCT) followed by D2 gastrectomy plus para-aortic lymph node dissection (PAND) is considered the s...
Autores principales: | Xu, Wei, Liu, Wentao, Wang, Lingquan, He, Changyu, Lu, Sheng, Ni, Zhentian, Hua, Zichen, Zhu, Zhenglun, Sah, Birendra Kumar, Yang, Zhongyin, Zheng, Yanan, Feng, Runhua, Li, Chen, Yao, Xuexin, Chen, Mingmin, Yan, Chao, Yan, Min, Zhu, Zhenggang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8444230/ https://www.ncbi.nlm.nih.gov/pubmed/34540676 http://dx.doi.org/10.3389/fonc.2021.709617 |
Ejemplares similares
-
Neoadjuvant Chemotherapy Versus Direct Surgery for Locally Advanced Gastric Cancer With Serosal Invasion (cT4NxM0): A Propensity Score-Matched Analysis
por: Xu, Wei, et al.
Publicado: (2021) -
Prediction Model of Tumor Regression Grade for Advanced Gastric Cancer After Preoperative Chemotherapy
por: Xu, Wei, et al.
Publicado: (2021) -
Oxaliplatin plus S-1 with intraperitoneal paclitaxel for the treatment of Chinese advanced gastric cancer with peritoneal metastases
por: Shi, Min, et al.
Publicado: (2021) -
Complications and risk factors for complications of implanted subcutaneous ports for intraperitoneal chemotherapy in gastric cancer with peritoneal metastasis
por: Yang, Zhongyin, et al.
Publicado: (2020) -
Clinical characteristics and outcomes of gastrointestinal stromal tumor patients receiving surgery with or without TKI therapy: a retrospective real-world study
por: Wang, Lingquan, et al.
Publicado: (2023)